Stanley L. Liauw, Janine Fricano, David Correa, Ralph R. Weichselbaum and Ashesh B. Jani Dose-escalated radiation therapy for intermediate-risk prostate cancer Cancer 115
Article first published online: 10 FEB 2009 | DOI: 10.1002/cncr.24176
The role of concurrent androgen deprivation therapy for men with intermediate-risk prostate cancer is uncertain in the setting of dose-escalated external beam radiation therapy. In this series of 238 men with intermediate-risk disease treated with radiation therapy, patients with ≥50% positive cores at biopsy had the highest risk for biochemical failure, and, therefore, may be the patients most likely to derive a benefit from androgen deprivation therapy.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.